Raymond James Financial Inc. purchased a new position in shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM – Free ...
We recently published a list of 15 Cheapest Stocks Insiders Are Buying In March. In this article, we are going to take a look ...
The sophomore, a member of the honors program at the School of Environmental and Biological Sciences, is pursuing a major in ...
Analysts anticipate PDS Biotechnology to report an earnings per share (EPS) of $-0.30. Anticipation surrounds PDS ...
Acknowledging the crucial role of start-ups in propelling India's biotech sector, Dr. Singh called for stronger handholding ...
Rep. Stephanie Bice is sending letters to the Trump administration and 23andme to raise alarm bells about the security risks ...
Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued ...
Stock analysts at Chardan Capital increased their FY2025 earnings per share (EPS) estimates for shares of Seres Therapeutics ...
Regional Centre for Biotechnology (RCB), Faridabad, Haryana-121001, has invited applications for admission to the MS-PhD ...
Sana Biotechnology, Inc.’s SANA share price has dipped by 11.16%, which has investors questioning if this is right time to ...
Puma Biotechnology will present clinical data on its drug neratinib in a poster presentation on April 28 at the 2025 AACR ...
MAIA Biotechnology, Inc. (MAIA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results